BeOne Medicines (BEIGF) Gains from Sales and Divestitures (2015 - 2017)
BeOne Medicines (BEIGF) reported Gains from Sales and Divestitures of $268750.0 for Q4 2017, up 504.68% year-over-year from $44445.0 in Q4 2016, and up 504.68% quarter-over-quarter from $44445.0 in Q4 2016.
BeOne Medicines (BEIGF) Gains from Sales and Divestitures (2015 - 2017) Analysis & Trends
BeOne Medicines (BEIGF) has 3 years of Gains from Sales and Divestitures data on file, last reported at $268750.0 in Q4 2017.
- Gains from Sales and Divestitures for Q4 2017 came in at $268750.0, up 504.68% year-over-year; the trailing twelve-month figure through Dec 2017 was $268750.0 (up 504.68% YoY), and the FY2017 annual result was $268750.0, up 504.68% from the prior year.
- Gains from Sales and Divestitures improved to $268750.0 in Q4 2017 per BEIGF's latest filing, from $44445.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $533333.0 in Q4 2015 and troughed at $44445.0 in Q4 2016.
- A 3-year average of $282176.0 and a median of $268750.0 in 2017 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2016 and 2017: Gains from Sales and Divestitures slumped 91.67% in 2016, then soared 504.68% in 2017.
- A 3-year view of Gains from Sales and Divestitures shows it stood at $533333.0 in 2015, then tumbled by 91.67% to $44445.0 in 2016, then soared by 504.68% to $268750.0 in 2017.
- Business Quant data shows BEIGF's Gains from Sales and Divestitures at $268750.0 in Q4 2017, $44445.0 in Q4 2016, and $533333.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 821,726.73 Bn | 821,726.69 Bn | - |
| 2 | Belite Bio | 57,768.00 Bn | 57,768.00 Bn | - |
| 3 | Quantum Biopharma | 16,655.88 Bn | 16,655.88 Bn | - |
| 4 | Legend Biotech | 3,540.00 Bn | 3,539.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,526.26 Bn | 1,526.24 Bn | - |
| 6 | Akari Therapeutics | 1,520.09 Bn | 1,520.09 Bn | - |
| 7 | Psyence Biomedical | 223.87 Bn | 223.87 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.47 Bn | 107.23 Bn | 2.59 Bn |
| 9 | Abivax | 91.22 Bn | 91.22 Bn | - |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 268,750.00 |
| Dec 31, 2017 | 268,750.00 |
| Dec 31, 2016 | 44,445.00 |
| Dec 31, 2016 | 44,445.00 |
| Dec 31, 2015 | 533,333.00 |
| Dec 31, 2015 | 533,333.00 |